Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apply for the Fierce AI Innovation Awards - Submissions close Thursday, June 18
Pharma
Pharma
FDA approves GSK, Spero's oral treatment for complicated UTIs
Four years after issuing a CRL, the FDA has signed off on GSK and Spero Therapeutics' Utebzi, an oral drug for complicated urinary tract infections.
Kevin Dunleavy
Jun 17, 2026 3:20pm
Verastem mulls options on approved asset in pancreatic cancer
Jun 17, 2026 3:00pm
Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
Brought to you by
DKSH
GSK runs first DTC ad for would-be asthma blockbuster Exdensur
Jun 17, 2026 11:55am
Precision oncology’s next challenge is translation
Brought to you by
Thermo Fisher Scientific
Novo's security breach claimed by dual hacking groups: reports
Jun 17, 2026 11:45am